Afstyla recombinant and Lorcaserin Extended-Release Tablets
Determining the interaction of Afstyla recombinant and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla recombinant-Lorcaserin Hydrochloride
- Afstyla recombinant-Lorcaserin Tablets
- Afstyla recombinant-Lorcet
- Afstyla recombinant-Lorcet Plus
- Afstyla recombinant-Lorcet Tablets
- Afstyla recombinant-Lorlatinib
- Lorcaserin Extended-Release Tablets-Aftera
- Lorcaserin Extended-Release Tablets-Aftertest Topical Pain Relief
- Lorcaserin Extended-Release Tablets-Agalsidase beta
- Lorcaserin Extended-Release Tablets-Agalsidase beta Intravenous
- Lorcaserin Extended-Release Tablets-Agenerase
- Lorcaserin Extended-Release Tablets-Aggrastat